TEICOPLANIN'S ADMINISTRATION IN ANTIBACTERIAL THERAPY OF PATIENTS WITH HIGH RISK OF DEVELOPMENT OF LIFE-THREATENING INFECTIONS

21 July 2015

Problems of modern antibacterial therapy explain the increased interest to glycopeptide antibiotics, active against most resistant Gram-positive cocci: methicillin- resistant staphilococci, penicillin-resistant pneumococci and enterococci. 

More details

to the list of publications